Information Provided By: 
Fly News Breaks for April 21, 2015
ALGN
Apr 21, 2015 | 06:48 EDT
As previously reported, Morgan Stanley upgraded Align Technology to Overweight from Equal Weight. The firm believes investor concerns surrounding patent expirations and the CEO transition are overstated and expects the company to be consensus expectations near-term. Morgan Stanley expects 2015-2016 growth acceleration to be driven by the Sirona collaboration, International growth, improvements in U.S. end markets, and digitization. The firm's price target is $79.
News For ALGN From the Last 2 Days
ALGN
Apr 26, 2024 | 08:36 EDT
Align Technology announced that it is planning to repurchase $150M of Align's common stock through open market repurchases under Align's $1.0 billion stock repurchase program that was approved by Align's Board of Directors in January 2023.
ALGN
Apr 25, 2024 | 08:09 EDT
Morgan Stanley raised the firm's price target on Align Technology to $360 from $344 and keeps an Overweight rating on the shares, which the firm thinks should rise on the Q1 beat and "surprise" FY24 revenue guidance raise. The raised guidance implies a "healthy" second half ramp, which "inherently comes with risks," but management expressed confidence in market stability and innovation drivers, the analyst tells investors.
ALGN
Apr 25, 2024 | 07:33 EDT
ALGN
Apr 25, 2024 | 06:55 EDT
ALGN
Apr 25, 2024 | 06:28 EDT
Baird raised the firm's price target on Align Technology to $370 from $333 and keeps an Outperform rating on the shares. The firm said the higher forward guide should especially be well-received given March consumer spending/ortho demand uncertainties, and while visibility over the next few quarters admittedly remains limited by macro, the company's consistency is improving.
